Previous close | 8.80 |
Open | 9.00 |
Bid | 8.80 |
Ask | 10.05 |
Strike | 90.00 |
Expiry date | 2025-01-17 |
Day's range | 9.00 - 9.00 |
Contract range | N/A |
Volume | |
Open interest | 43 |
Moderna (MRNA) closed the most recent trading day at $171.06, moving +0.46% from the previous trading session.
In last-year's difficult market, growth stocks were among the first to suffer. Why should we be confident about growth stocks? Moderna (NASDAQ: MRNA) went from zero product revenue prior to the pandemic to about $18 billion annually over the past two years.
FREMONT, Calif., February 03, 2023--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the companies have signed a new agreement to continue using the Personalis NeXT Platform® as part of upcoming clinical studies evaluating mRNA-4157/V940, an investigational personalized cancer vaccine, jointly developed by Moderna and Merck, kn